Literature DB >> 26105838

Introduction to ISSHP new classification of preeclampsia.

Andrea L Tranquilli1.   

Abstract

The classification of the hypertensive disorders of pregnancy has always been a crucial point, especially in the scientific literature, to compare results from different series. Some of the classes have been reviewed during time, and some new ones have been added, paralleling the increased knowledge of the diseases and syndromes. Among the interests of a society there is the sharing of a common language and the guidance to give to scientific authors and editors for better presentation of their results and outcomes. Still leaving unchanged the definition of the five major classes of the hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, chronic hypertension, preeclampsia superimposed on chronic hypertension, eclampsia) we realized that in the last years emerged a need to better define some forms of preeclampsia, especially in terms of severity and time of onset and indicated delivery. This is why the International Committee of the International Society for the Study of Hypertension in Pregnancy (ISSHP) was requested to come to a consensus, by responding to a questionnaire, on the thresholds to define "severe preeclampsia", and "early onset preeclampsia", and on which parameters to use to define the HELLP Syndrome and which other definitions may be added. There was an agreement to define "severe preeclampsia" by blood pressure values >160mmHg systolic or 110mmHg diastolic. The amount of proteinuria was considered not useful to define the severity. The HELLP syndrome was considered a feature to include in the severe classification, and that could be identified by a reduction of platelet count below <100,000/dl, an elevation of ALT or AST twofold the upper limit of normal, and an elevated LDH (twofold the upper reference limit or greater than 650IU/l). There was an agreement to define "early-onset preeclampsia" as that occurring before 34 weeks. The results of this survey can help in updating the previous ISSHP classification.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Year:  2013        PMID: 26105838     DOI: 10.1016/j.preghy.2013.04.006

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  19 in total

1.  Aspirin in the prevention of preeclampsia: the conundrum of how, who and when.

Authors:  Renuka Shanmugalingam; Annemarie Hennessy; Angela Makris
Journal:  J Hum Hypertens       Date:  2018-09-19       Impact factor: 3.012

2.  Successful pregnancy in a CKD patient on a low-protein, supplemented diet: an opportunity to reflect on CKD and pregnancy in Mexico, an emerging country.

Authors:  Julia Nava; Silvia Moran; Veronica Figueroa; Adriana Salinas; Margy Lopez; Rocio Urbina; Abril Gutierrez; Jose Luis Lujan; Alejandra Orozco; Rafael Montufar; Giorgina B Piccoli
Journal:  J Nephrol       Date:  2017-09-16       Impact factor: 3.902

3.  Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology.

Authors:  Roberto Romero; Eunjung Jung; Tinnakorn Chaiworapongsa; Offer Erez; Dereje W Gudicha; Yeon Mee Kim; Jung-Sun Kim; Bomi Kim; Juan Pedro Kusanovic; Francesca Gotsch; Andreea B Taran; Bo Hyun Yoon; Sonia S Hassan; Chaur-Dong Hsu; Piya Chaemsaithong; Nardhy Gomez-Lopez; Lami Yeo; Chong Jai Kim; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2022-09-03       Impact factor: 10.693

Review 4.  Imaging of Headache in Pregnancy.

Authors:  Maryna Skliut; Dara G Jamieson
Journal:  Curr Pain Headache Rep       Date:  2016-10

5.  Evidence of under-reporting of early-onset preeclampsia using register data.

Authors:  Julia F Simard; Marios Rossides; Anna-Karin Wikström; Titilola Falasinnu; Kristin Palmsten; Elizabeth V Arkema
Journal:  Paediatr Perinat Epidemiol       Date:  2021-05-06       Impact factor: 3.103

Review 6.  A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.

Authors:  Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2016-03-17       Impact factor: 3.902

7.  Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity.

Authors:  M G Nikolaeva; A P Momot; M S Zainulina; N N Yasafova; I A Taranenko
Journal:  Thromb J       Date:  2021-06-05

Review 8.  Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the Disease.

Authors:  Adam M Sheikh; Heather Yvonne Small; Gemma Currie; Christian Delles
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

9.  Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia.

Authors:  Ya-Jing Pan; Lian He; Si-Jia Zhou; Li-Jie Zhang; Ai-Hua Zhang; Yang-Yu Zhao
Journal:  J Hum Hypertens       Date:  2018-07-10       Impact factor: 3.012

10.  Accurate Prediction of Total PlGF (Placental Growth Factor) From Free PlGF and sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1): Evidence for Markedly Elevated PlGF Levels in Women With Acute Fatty Liver of Pregnancy.

Authors:  Rugina I Neuman; Langeza Saleh; Koen Verdonk; Anton H van den Meiracker; Henk Russcher; Herold J Metselaar; Willy Visser; A H Jan Danser
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.